Insider · CIK 0001614875

Gasmi Mehdi

Reports to the SEC for 1 company · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001614875

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-05-12	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-07-20	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$4.80	+$24K	279,442
2020-07-20	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−5,000 sh	$17.60	−$88K	274,442
2020-07-20	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	78,000
2020-06-23	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2020-06-22	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+23.6K sh	$4.80	+$113K	298,047
2020-06-22	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−23.6K sh	$25.06	−$592K	274,442
2020-06-22	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−23.6K sh	—	—	83,000
2020-06-18	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.1K sh	$4.80	+$53.4K	285,569
2020-06-18	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−11.1K sh	$25.01	−$278K	274,442
2020-06-18	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.1K sh	—	—	106,605
2020-06-17	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+268 sh	$4.80	+$1,286.4	274,710
2020-06-17	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−268 sh	$25.01	−$6,702.707	274,442
2020-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−268 sh	—	—	117,732
2020-06-15	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.80	+$48K	284,442
2020-06-15	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−5,000 sh	$21.01	−$105K	279,442
2020-06-15	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−1,416 sh	$21.93	−$31K	278,026
2020-06-15	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−3,425 sh	$23.00	−$78.8K	274,601
2020-06-15	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−159 sh	$23.59	−$3,751.176	274,442
2020-06-15	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	118,000
2020-05-21	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,599 sh	$4.80	+$17.3K	278,041
2020-05-21	Adverum Biotechnologies, Inc.S Sale	Director	SSale	+3,599 sh	$20.02	+$72K	274,442
2020-05-21	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,599 sh	—	—	128,000
2020-05-20	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,401 sh	$4.80	+$6,724.8	275,843
2020-05-20	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−1,401 sh	$20.01	−$28K	274,442
2020-05-20	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,401 sh	—	—	131,599
2020-05-18	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$4.80	+$24K	279,442
2020-05-18	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−4,700 sh	$18.11	−$85.1K	274,742
2020-05-18	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−300 sh	$19.03	−$5,709	274,442
2020-05-18	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	133,000
2020-05-06	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$4.80	+$120K	299,442
2020-05-06	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−25K sh	$20.03	−$501K	274,442
2020-05-06	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	138,000
2020-05-05	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.80	+$48K	284,442
2020-05-05	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−10K sh	$16.26	−$163K	274,442
2020-05-05	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	163,000
2020-02-18	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$4.80	+$24K	263,979
2020-02-18	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−5,000 sh	$16.23	−$81.2K	258,979
2020-02-18	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	—	—	173,000
2020-02-12	Adverum Biotechnologies, Inc.F Tax Payment	Director	FTax Payment	−31.5K sh	$11.33	−$357K	289,936
2020-02-12	Adverum Biotechnologies, Inc.F Tax Payment	Director	FTax Payment	−15.5K sh	$15.05	−$233K	274,442
2020-02-12	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.80	+$48K	284,442
2020-02-12	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−10K sh	$15.07	−$151K	274,442
2020-02-12	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	178,000
2020-02-12	Adverum Biotechnologies, Inc.F Tax Payment	Director	FTax Payment	−31.5K sh	$11.33	−$356K	289,967
2020-02-12	Adverum Biotechnologies, Inc.F Tax Payment	Director	FTax Payment	−15.5K sh	$15.05	−$233K	258,979
2020-02-12	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.80	+$48K	268,979
2020-02-12	Adverum Biotechnologies, Inc.S Sale	Director	SSale	−10K sh	$15.07	−$151K	258,979
2020-02-12	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	178,000
2020-02-09	Adverum Biotechnologies, Inc.F Tax Payment	Director	FTax Payment	−11.6K sh	$10.24	−$118K	309,867

Recent filings

Accepted (ET)
May 144
Gasmi Mehdi0001209191-21-032955
SEC(opens sec.gov)
Jul 224
Gasmi Mehdi0001209191-20-043426
SEC(opens sec.gov)
Jun 254
Gasmi Mehdi0001209191-20-038964
SEC(opens sec.gov)
Jun 234
Gasmi Mehdi0001209191-20-038635
SEC(opens sec.gov)
Jun 184
Gasmi Mehdi0001209191-20-037769
SEC(opens sec.gov)
Jun 174
Gasmi Mehdi0001209191-20-037339
SEC(opens sec.gov)

Companies

Adverum Biotechnologies, Inc.Director

Address

C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A

MENLO PARK, CA, 94025